Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell, Metastatic Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00401128
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
The Cleveland Clinic 9
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Testing effectiveness (Phase 2)WithdrawnNCT06361810
What this trial is testing

PSMA Therapy and Immunotherapy in Kidney Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Very early researchLooking for participantsNCT07645690
What this trial is testing

The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
Chinese PLA General Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04810078
What this trial is testing

Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

Who this might be right for
Clear Cell Renal Cell Carcinoma
Bristol-Myers Squibb 681
Early research (Phase 1)Active Not RecruitingNCT06049576
What this trial is testing

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Ended earlyNCT03334409
What this trial is testing

Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more
Academic and Community Cancer Research United 5
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Study completedNCT06389682
What this trial is testing

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma Metastatic
Norroy Bioscience Co., LTD 19
Testing effectiveness (Phase 2)Study completedNCT03075423
What this trial is testing

Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Goethe University 316
Testing effectiveness (Phase 2)Ended earlyNCT00323791
What this trial is testing

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Medicine and Dentistry of New Jersey 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT01684397
What this trial is testing

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer
Roswell Park Cancer Institute 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277972
What this trial is testing

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

Who this might be right for
RCC, Renal Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 36
Testing effectiveness (Phase 2)Study completedNCT02535533
What this trial is testing

SLM + Axitinib for Clear Cell RCC

Who this might be right for
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
Mohammed Milhem 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022343
What this trial is testing

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8
Emory University 22
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)WithdrawnNCT03693573
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT03066427
What this trial is testing

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.

Who this might be right for
Clear Cell Renal Carcinoma
Spanish Oncology Genito-Urinary Group 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06279403
What this trial is testing

Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaImmune Checkpoint InhibitorsCytoreductive Nephrectomy
RenJi Hospital 20
Early research (Phase 1)Looking for participantsNCT07195682
What this trial is testing

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 281
Next Page